Cargando…
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
Background: bladder cancer is one of the most common urinary tract malignancies. Establishment of robust predictors of disease progression and outcome is important for personalizing treatment of non-muscular invasive bladder carcinoma (NMIBC). In this study we evaluated association of PD-L1 expressi...
Autores principales: | Blinova, Ekaterina, Buzdin, Anton, Enikeev, Dmitry, Roshchin, Dmitry, Suntsova, Maria, Samyshina, Elena, Drobyshev, Aleksey, Deryabina, Olga, Demura, Tatiana, Blinov, Dmitry, Shich, Evgenia, Barakat, Haydar, Borger, Pieter, Merinov, Dmitrij, Kachmazov, Aleksandr, Serebrianyi, Stanislav, Tumutolova, Oxana, Potoldykova, Natalia, Zhdanov, Pavel, Grigoryan, Vagarshak, Perepechin, Dmitrij |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700587/ https://www.ncbi.nlm.nih.gov/pubmed/33238591 http://dx.doi.org/10.3390/life10110305 |
Ejemplares similares
-
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
por: Blinova, Ekaterina, et al.
Publicado: (2020) -
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma
por: Blinova, Ekaterina, et al.
Publicado: (2021) -
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
por: Blinova, Ekaterina, et al.
Publicado: (2019) -
Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression
por: Samishina, Elena A., et al.
Publicado: (2019) -
Cerium-Containing N-Acetyl-6-Aminohexanoic Acid Formulation Accelerates Wound Reparation in Diabetic Animals
por: Blinova, Ekaterina, et al.
Publicado: (2021)